genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2022
Brain cancer
Cancer
Drug Targets Link between Glioblastoma Stem Cells and Circadian Clock Proteins
Cancer
Uncovering How Medulloblastoma Tumors Develop
Cancer
Mathematical Modeling Could Lead to Simple Blood Tests for Brain Tumors
Cancer
Novel Glioblastoma Drug Targets Familiar DNA Modifying Mechanism
Cancer
Brain Cancer Therapy Shows Promise in Pediatric Clinical Trial
Cancer
Stopping Cancer Cells’ Movement and Changing Their Direction
OMICs
Spreading the Use of Spatial Transcriptomics
Cancer
Biomarkers Identified as Potential Targets for Glioblastoma
Cancer
StockWatch: Bluebird Surges on FDA Advice, but Only Briefly
Cancer
Bridge Therapy for Children with High-Risk Neuroblastoma
1
2
3
4
...
22
Page 3 of 22
Scroll Up
Scroll Up
